Aubagio (teriflunomide) affects the immune system and reduces swelling and inflammation in the nervous system.
Aubagio is used to treat relapsing forms of multiple sclerosis in adults (including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease).
Aubagio is not a cure for MS.
